Current And Emerging Drugs Continue To Struggle For Patient Share In The Treatment Of Major Depressive Disorder
Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a drug’s long-term efficacy in preventing recurrence of depressive mood episodes in patients who suffer from major depressive disorder, is the attribute that most influences psychiatrists’ prescribing decisions in the treatment of this disorder.
More: continued here
Filed under: Depression on July 16th, 2008